|
🦁
|
OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Dinah Zur,
Matias Iglicki,
C. Busch,
A. Invernizzi,
Miriana Mariussi,
A. Loewenstein
|
7 |
2017 |
7
🦁
|
|
🦁
|
Postsurgical Cystoid Macular Edema.
Dinah Zur,
A. Loewenstein
|
7 |
2017 |
7
🦁
|
|
🐜
|
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study
17 auth.
Matias Iglicki,
C. Busch,
Dinah Zur,
Mali Okada,
Miriana Mariussi,
J. Chhablani,
Z. Cebeci,
S. Fraser-Bell,
V. Chaikitmongkol,
A. Couturier,
...
E. Giancipoli,
M. Lupidi,
P. J. Rodríguez-Valdés,
M. Rehak,
A. Fung,
M. Goldstein,
A. Loewenstein
|
7 |
2019 |
7
🐜
|
|
🐜
|
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
22 auth.
C. Busch,
Dinah Zur,
S. Fraser-Bell,
I. Laíns,
A. R. Santos,
M. Lupidi,
C. Cagini,
P. Gabrielle,
A. Couturier,
Valérie Mané-Tauty,
...
E. Giancipoli,
G. Ricci,
Z. Cebeci,
P. J. Rodríguez-Valdés,
V. Chaikitmongkol,
Atchara Amphornphruet,
Isaac Hindi,
Kushal Agrawal,
J. Chhablani,
A. Loewenstein,
Matias Iglicki,
M. Rehak
|
6 |
2018 |
6
🐜
|
|
🦁
|
The Role of Steroids in the Management of Diabetic Macular Edema
Dinah Zur,
Matias Iglicki,
A. Loewenstein
|
6 |
2019 |
6
🦁
|
|
🦁
|
Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant
14 auth.
Dinah Zur,
Matias Iglicki,
A. Sala-Puigdollers,
J. Chhablani,
M. Lupidi,
S. Fraser-Bell,
T. S. Mendes,
V. Chaikitmongkol,
Z. Cebeci,
Dolev Dollberg,
...
C. Busch,
A. Invernizzi,
Z. Habot-Wilner,
A. Loewenstein
|
6 |
2020 |
6
🦁
|
|
🐬
|
Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the ‘DR-Pro-DEX Study’
Matias Iglicki,
Dinah Zur,
C. Busch,
Mali Okada,
A. Loewenstein
|
6 |
2018 |
6
🐬
|
|
🦁
|
Disorganization of Retinal Inner Layers as a Biomarker for Idiopathic Epiretinal Membrane After Macular Surgery-The DREAM Study.
7 auth.
Dinah Zur,
Matias Iglicki,
Lital Feldinger,
Shulamit Schwartz,
M. Goldstein,
A. Loewenstein,
...
A. Barak
|
6 |
2018 |
6
🦁
|
|
🐜
|
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
21 auth.
Marc J Sirks,
E. H. V. van Dijk,
Noa Rosenberg,
C. Hollak,
Stamatios Aslanis,
Chui Ming Gemmy Cheung,
I. Chowers,
Chiara M. Eandi,
K. B. Freund,
F. Holz,
...
Peter K. Kaiser,
Andrew J. Lotery,
K. Ohno-Matsui,
G. Querques,
Y. Subhi,
R. Tadayoni,
C. Wykoff,
Dinah Zur,
R. Diederen,
C. Boon,
R. Schlingemann
|
5 |
2022 |
5
🐜
|
|
🐜
|
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
24 auth.
C. Busch,
S. Fraser-Bell,
Matias Iglicki,
M. Lupidi,
A. Couturier,
V. Chaikitmongkol,
E. Giancipoli,
P. J. Rodríguez-Valdés,
P. Gabrielle,
I. Laíns,
...
A. R. Santos,
Z. Cebeci,
Atchara Amphornphruet,
Valentin Degenhardt,
J. Unterlauft,
C. Cagini,
Valérie Mané-Tauty,
G. D’Amico Ricci,
Isaac Hindi,
Kushal Agrawal,
J. Chhablani,
A. Loewenstein,
Dinah Zur,
M. Rehak
|
5 |
2019 |
5
🐜
|
